Carlotta Dionigi

Carlotta Dionigi

Auto-generated profile, based on publicly available information

Carlotta Dionigi

Department of Periodontology, Institute of Odontology The Sahlgrenska Academy at University of Gothenburg Gothenburg Sweden

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2022 in Clinical Oral Implants Research
Verified
Journal Article
Open access
JDJan Derks
Jan Derks
AOAlberto Ortiz‐Vigón
Alberto Ortiz‐Vigón
AGAdrián Guerrero
Adrián Guerrero
MDMauro Donati
Mauro Donati
EBEriberto Bressan
Eriberto Bressan
TBTord Berglundh
Tord Berglundh
Objective: To evaluate the potential benefit of the use of a bone substitute material in the reconstructive surgical therapy of peri‐implantitis.Methods: In this multicenter randomized clinical trial, 138 patients (147 implants) with peri‐implantitis were treated surgically, randomized by coin toss to either a control (access flap surgery) or a test group (reconstructive surgery using bone substitute material). Clinical assessments, including probing pocket depth (PPD), bleeding and suppuration on probing (BOP & SOP) as well as soft tissue recession (REC), were recorded at baseline, 6 and 12 months. Marginal bone levels (MBL), measured on intra‐oral radiographs, and patient‐reported outcomes (PROs) were recorded at baseline and 12 months. No blinding to group allocation was performed. The primary outcome at 12 months was a composite measure including (i) implant not lost, (ii) absence of BOP/SOP at all aspects, (iii) PPD ≤5 mm at all aspects and (iv) ≤1 mm recession of mucosal margin on the buccal aspect of the implant. Secondary outcomes included (i) changes of MBL, (ii) changes of PPD, BOP%, and buccal KM, (iii) buccal REC and (iv) patient‐reported outcomes.Results: During follow‐up, four implants (one in the test group, three in the control group) in four patients were removed due to disease progression. At 12 months, a total of 69 implants in the test and 68 implants in the control group were examined. Thus, 16.4% and 13.5% of implants in the test and control group, respectively, met all predefined criteria of the composite outcome. PPD reduction and MBL gain were 3.7 mm and about 1.0 mm in both groups. Reduction in mean BOP% varied between 45% (test) and 50% (control), without significant differences between groups. Buccal REC was less pronounced in the test group (M = 0.7, SD = 0.9 mm) when compared to controls (M = 1.1, SD = 1.5 mm). PROs were favorable in both groups without significant differences. One case of allergic reaction to the antibiotic therapy was recorded. No other adverse events were noted.Conclusions: Surgical therapy of peri‐implantitis effectively improved the clinical and radiographic status at 12 months. While the use of a bone substitute material did not improve reductions of PPD and BOP, buccal REC was less pronounced in the test group. Patient satisfaction was high in both groups.

11 July 2022 in Journal of Clinical Periodontology
Verified
Journal Article
Open access
JDJan Derks
Jan Derks
YIYuki Ichioka
Yuki Ichioka
CDCarlotta Dionigi
Carlotta Dionigi
ATAnna Trullenque‐Eriksson
Anna Trullenque‐Eriksson
JBJessica Berglundh
Jessica Berglundh
FGFilippo Graziani
Filippo Graziani
Objectives: To evaluate outcome measures, methods of assessment, and analysis in clinical studies on the prevention and management of peri‐implant mucositis and peri‐implantitis.Methods: Systematic electronic searches (CENTRAL/MEDLINE/SCOPUS) up to April 2021 were conducted to identify longitudinal clinical studies with ≥10 patients on either the prevention or management of peri‐implant diseases. Outcome measures of this analysis were the choice of outcome measures, methods of assessment, and analytical methods. Risk of bias was evaluated according to study design. Data were extracted into evidence tables and outcomes were analysed in a descriptive manner.Results: The analysis of the 159 selected studies revealed that probing pocket depth (PPD) and bleeding/suppuration on probing (BOP) were reported in 89% and 87% of all studies, respectively. Additional outcome measures included plaque scores (reported in 64% of studies), radiographic outcomes (49%), soft tissue dimensions (34%), and composite outcomes (26%). Adverse events (8%) and patient‐reported outcomes (6%) were only rarely mentioned. A primary outcome measure was clearly defined only in 36% of studies. Data on PPD, radiographic outcomes, and soft tissue dimensions were primarily reported as mean values and rarely as frequency distributions. For radiographic outcomes and soft tissue dimensions, it was frequently unclear how clustered data were handled.Conclusions: PPD and BOP were routinely reported in studies on the prevention and management of peri‐implant mucositis and peri‐implantitis, while composite outcomes, adverse events, and patient‐reported outcomes were only infrequently described.

6 March 2023 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
ERErik Regidor
Erik Regidor
AOAlberto Ortiz‐Vigón
Alberto Ortiz‐Vigón
MRMario Romandini
Mario Romandini
CDCarlotta Dionigi
Carlotta Dionigi
JDJan Derks
Jan Derks
MSMariano Sanz
Mariano Sanz

17 July 2023 in Journal of Clinical Periodontology
Verified
Journal Article
Open access
YIYuki Ichioka
Yuki Ichioka
ATAnna Trullenque‐Eriksson
Anna Trullenque‐Eriksson
AOAlberto Ortiz‐Vigón
Alberto Ortiz‐Vigón
AGAdrián Guerrero
Adrián Guerrero
MDMauro Donati
Mauro Donati
JDJan Derks
Jan Derks
Aim: To identify predictors of treatment outcomes following surgical therapy of peri‐implantitis.Materials and Methods: We performed a secondary analysis of data from a randomized controlled trial (RCT) comparing access flap with or without bone replacement graft. Outcomes at 12 months were probing pocket depth (PPD), bleeding on probing (BOP), soft‐tissue recession (REC) and marginal bone level (MBL) change. Multilevel regression analyses were used to identify predictors. We also built an explanatory model for residual signs of inflammation.Results: Baseline PPD was the most relevant predictor, showing positive associations with final PPD, REC and MBL gain, and negative association with probability of pocket closure. Smokers presented higher residual PPD. Absence of keratinized mucosa at baseline increased the probability of BOP but was otherwise not indicative of outcomes. Plaque at 6 weeks was detrimental in terms of residual PPD and BOP. Treatment allocation had an effect on REC. Final BOP was explained by residual PPD ≥6 mm and plaque at more than two sites.Conclusions: Baseline PPD was the most relevant predictor of the outcomes of surgical therapy of peri‐implantitis. Pocket closure should be a primary goal of treatment. Bone replacement grafts may be indicated in aesthetically demanding cases to reduce soft‐tissue recession. The importance of smoking cessation and patient‐performed plaque control is also underlined.

11 July 2022 in Clinical Oral Implants Research
Verified
Journal Article
Open access
JDJan Derks
Jan Derks
YIYuki Ichioka
Yuki Ichioka
CDCarlotta Dionigi
Carlotta Dionigi
ATAnna Trullenque‐Eriksson
Anna Trullenque‐Eriksson
JBJessica Berglundh
Jessica Berglundh
FGFilippo Graziani
Filippo Graziani
Objectives: To evaluate outcome measures, methods of assessment, and analysis in clinical studies on the prevention and management of peri‐implant mucositis and peri‐implantitis.Methods: Systematic electronic searches (CENTRAL/MEDLINE/SCOPUS) up to April 2021 were conducted to identify longitudinal clinical studies with ≥10 patients on either the prevention or management of peri‐implant diseases. Outcome measures of this analysis were the choice of outcome measures, methods of assessment, and analytical methods. Risk of bias was evaluated according to study design. Data were extracted into evidence tables and outcomes were analysed in a descriptive manner.Results: The analysis of the 159 selected studies revealed that probing pocket depth (PPD) and bleeding/suppuration on probing (BOP) were reported in 89% and 87% of all studies, respectively. Additional outcome measures included plaque scores (reported in 64% of studies), radiographic outcomes (49%), soft tissue dimensions (34%), and composite outcomes (26%). Adverse events (8%) and patient‐reported outcomes (6%) were only rarely mentioned. A primary outcome measure was clearly defined only in 36% of studies. Data on PPD, radiographic outcomes, and soft tissue dimensions were primarily reported as mean values and rarely as frequency distributions. For radiographic outcomes and soft tissue dimensions, it was frequently unclear how clustered data were handled.Conclusions: PPD and BOP were routinely reported in studies on the prevention and management of peri‐implant mucositis and peri‐implantitis, while composite outcomes, adverse events, and patient‐reported outcomes were only infrequently described.

18 March 2025 in Communications Medicine
Verified
Journal Article
Open access
PDF file
CDCarlotta Dionigi
Carlotta Dionigi
GNGyula Nagy
Gyula Nagy
JDJan Derks
Jan Derks
YIYuki Ichioka
Yuki Ichioka
CTCristiano Tomasi
Cristiano Tomasi
TBTord Berglundh
Tord Berglundh
Background: Dental implants are one of the most frequently used medical devices for therapeutic purposes in dentistry. Peri-implantitis is a severe, microbial biofilm-associated condition, characterized by inflammation in peri-implant soft tissues and destruction of supporting bone. It has been suggested that metal particles originating from the implant may influence the local host response to microbial biofilms. Methods: Soft tissue biopsies were collected from implant sites with and without peri-implantitis in 21 patients. Micro Proton-induced X-ray Emission (µ-PIXE) analysis was used to localize, quantify and characterize titanium micro-particles within tissues. RNA sequencing was performed to evaluate potential associations between titanium micro-particles and gene expression profiles in peri-implantitis lesions. Results: Titanium micro-particles are consistent findings in soft tissues surrounding dental implants. Their occurrence varies across patients but not between sites with and without peri-implantitis within the same individual. Most particles reside in a 2-mm wide tissue portion close to the implant/tissue interface. The time in function of the implants does not influence the volumetric density of titanium micro-particles, while implant systems do. Fourteen differentially expressed genes are identified when comparing peri-implantitis samples with high and low densities of titanium micro-particles. The gene-set enrichment analysis reveals functions related to the regulation of the immune response and epithelial development. Conclusions: The present results indicate that titanium micro-particles are commonly found in tissues surrounding dental implants and are not associated with the occurrence of peri-implantitis.